Abnormal GSK-3α and GSK-3β activities have been associated with multiple diseases including diabetes, inflammation, cancer, bipolar disorder and neurodegenerative diseases including Parkinson’s disease (PD), Alzheimer’s disease (AD) and Huntington’s disease (HD)9–13. Here, GSK3A is linked to Parkinson disease.